Study finds excellent clinical ART responses from Kenyans. Toxicities were top reason for switch.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007630:Kenya; D016896:Treatment Outcome
D019380:Anti-HIV Agents